Showing results (141-150 of 531) with videos related to
Sort By:
Pageof 54
Neuroscience Letters|August 17, 1992
Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's diseaseE Sofic, K W Lange, K Jellinger, et al.Lancet (London, England)|February 26, 1977
Implications of combined treatment with 'Madopar' and L-deprenil in Parkinson's disease. A long-term studyW Birkmayer, P Riederer, L Ambrozi, et al.Journal of Neural Transmission. General Section|January 1, 1993
L-glutamate and L-aspartate concentrations in the developing and aging human putamen tissueM E Kornhuber, J Kornhuber, W Retz, et al.Free Radical Research|November 8, 2001
A highly sensitive method for the determination of protein bound 3,4-dihydroxyphenylalanine as a marker for post-translational protein hydroxylation in human tissues ex vivoR Harth, M Gerlach, P Riederer, et al.Infusionstherapie Und Klinische Ernahrung|October 1, 1987
[Changes in organic acids in plasma and cerebrospinal fluid in cerebral infarct]W D Rausch, K Schnecker, J Bruck, et al.Acta Neurologica Scandinavica. Supplementum|January 1, 1989
Neurochemical perspectives to the function of monoamine oxidaseP Riederer, C Konradi, G Hebenstreit, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|October 14, 2004
Dopamine receptor agonists in the therapy of Parkinson's diseaseP Foley, M Gerlach, K L Double, et al.Annals of the New York Academy of Sciences|February 15, 2000
A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer's diseaseL Frölich, D Blum-Degen, P Riederer, et al.Parkinsonism & Related Disorders|July 2, 2008
MAO-B inhibitors: multiple roles in the therapy of neurodegenerative disorders?P Foley, M Gerlach, M B Youdim, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|August 12, 1999
Parkinson's disease: a major hypokinetic basal ganglia disorderJ Sian, M Gerlach, M B Youdim, et al.Pageof 54